Ordinary Index Rebalancing in the Solactive BBVA Health & Wellness Index | May 2022

In the ordinary rebalance the following composition will be implemented effective open 12.05.2022:

ABBVIE INC
ALCON INC
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD
ALIGN TECHNOLOGY INC
AMGEN INC
ANTHEM INC
APPLE INC
BECTON DICKINSON AND CO
BIONTECH SE
BRISTOL-MYERS SQUIBB CO
CARL ZEISS MEDITEC AG
CENTENE
CERNER CORP
CONVATEC GROUP PLC
COOPER COMPANIES INC
CSL LTD ORD
DANAHER CORP
DEXCOM INC
ESTEE LAUDER COMPANIES INC
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
FRESENIUS SE & CO KGAA
GENMAB A/S
GILEAD SCIENCES INC
GLAXOSMITHKLINE PLC
HORIZON THERAPEUTICS PLC
ILLUMINA INC
INCYTE CORP
IQVIA HOLDINGS INC
JOHNSON & JOHNSON
L OREAL SA
LONZA GROUP AG
MERCK & CO. INC.
MODERNA INC
NOVO NORDISK A/S
PEPTIDREAM INC
PFIZER INC
PROCTER & GAMBLE CO
RECORDATI SPA
REGENERON PHARMACEUTICALS
SANTEN PHARMACEUTICAL CO LTD ORD
SARTORIUS AG PREF
SIEMENS AG
STERIS PLC
TAKEDA PHARMACEUTICAL
THULE GROUP AB/THE
UNITEDHEALTH GROUP INC
VEEVA SYSTEMS INC
VERTEX PHARMACEUTICALS INC
WEST PHARMACEUTICAL SERVICES INC
ZIMMER BIOMET HOLDINGS INC